Sandra Vieira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sandra Vieira has a total of 187 co-authors. Here are the top co-authors by number of shared publications:
- Andrea Mechelli
Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK
2 shared publications Barnaby Nelson
2 shared publicationsCelso Arango
2 shared publicationsChristy Lai Ming Hui
2 shared publications- Covadonga Martinez Díaz-Caneja
Hospital General Universitario Gregorio Marañón
2 shared publications Daniel Mamah
2 shared publications
Latest Publications
- Open Access
- 23 October 2026
- Published by Elsevier in Biological Psychiatry
Positive–affective and negative–cognitive brain–behavior axes in clinical high risk for psychosis
- 23 October 2026
- Published by Elsevier in Biological Psychiatry
Open AccessPositive–affective and negative–cognitive brain–behavior axes in clinical high risk for psychosis
- Open Access
- 1 October 2026
- Published by Wiley in Early Intervention in Psychiatry
- Vol. 20 (10)
Thriving in the City: An Urban Living Lab to Facilitate Recovery From Psychosis
Aim: Protective factors and resources to recovery in urban milieus remain poorly understood, calling for user‐led initiatives to develop relevant interventions embedded in patients' daily‐life environments. Experience‐based co‐design is key to need‐based interventions in real‐life settings and calls for novel methodologies. Observation: This multi‐stakeholder (service users, psychiatrists, geographers, community actors and public authorities) initiative aims to identify key elements of an ‘urban recovery milieu for psychosis’ in Lausanne, Switzerland based on a Living Lab approach. Beyond questions of usage, feasibility and acceptability, we will identify which types of interventions are more useful for which group of patients. This pilot phase may pave the way towards a future randomized control trial and the definition of the most appropriate sample size for it. Results: Qualitative data are collected through field notes, audio‐recorded walk‐alongs, workshops and focus groups with care teams and participants. The quantitative analysis is based on observational and correlational study design. We will assess how 55 patients of two psychosis‐specialized cohorts use the urban interventions in their day‐to‐day practices and monitor psychometric variables before and after the experimentation. The data stems from tailor‐made questionnaires (City avoidance questionnaire, Urban remediation questionnaire, etc.), clinical rating scales (ASI, RAS, TEPS, ISMI and CRDPS) and routine follow‐up procedures (SOFAS, GAF, CGI, WHOQOL and PAS). Discussion: Additionally, insights from this study will inform mental health plan on municipal level and be upscaled for broader public benefits.
- 1 October 2026
- Published by Wiley in Early Intervention in Psychiatry
- Vol. 20 (10)
Open AccessThriving in the City: An Urban Living Lab to Facilitate Recovery From Psychosis
Aim: Protective factors and resources to recovery in urban milieus remain poorly understood, calling for user‐led initiatives to develop relevant interventions embedded in patients' daily‐life environments. Experience‐based co‐design is key to need‐based interventions in real‐life settings and calls for novel methodologies. Observation: This multi‐stakeholder (service users, psychiatrists, geographers, community actors and public authorities) initiative aims to identify key elements of an ‘urban recovery milieu for psychosis’ in Lausanne, Switzerland based on a Living Lab approach. Beyond questions of usage, feasibility and acceptability, we will identify which types of interventions are more useful for which group of patients. This pilot phase may pave the way towards a future randomized control trial and the definition of the most appropriate sample size for it. Results: Qualitative data are collected through field notes, audio‐recorded walk‐alongs, workshops and focus groups with care teams and participants. The quantitative analysis is based on observational and correlational study design. We will assess how 55 patients of two psychosis‐specialized cohorts use the urban interventions in their day‐to‐day practices and monitor psychometric variables before and after the experimentation. The data stems from tailor‐made questionnaires (City avoidance questionnaire, Urban remediation questionnaire, etc.), clinical rating scales (ASI, RAS, TEPS, ISMI and CRDPS) and routine follow‐up procedures (SOFAS, GAF, CGI, WHOQOL and PAS). Discussion: Additionally, insights from this study will inform mental health plan on municipal level and be upscaled for broader public benefits.
- Open Access
- 26 May 2020
- Published by Wiley in Early Intervention in Psychiatry
- Vol. 15 (3) , 606-615
Examining service‐user perspectives for the development of a good outcome checklist for individuals at clinical high risk for psychosis
Aims: Around 15% of patients at clinical high risk for psychosis (CHR‐P) experience symptomatic remission and functional recovery at follow‐up, yet the definition of a good outcome (GO) in this population requires further development. Outcomes are typically designed and rated by clinicians rather than patients, to measure adverse as opposed to GOs. Here we investigate how CHR‐P subjects define a GO, with the aim of developing a checklist that could be used to measure GO in this clinical group.Methods: A set of GO‐focused questions were designed in collaboration with a service‐user. CHR‐P patients (n = 48) were asked to rate the importance of items that could indicate short‐term (1 year) and long‐term (5 years) GO. These items were then ranked using the relative importance index (RII).Results: Patients rated improvement in subjective wellbeing (RII = 0.829) and non‐specific presenting symptoms (RII = 0.817) amongst the factors most important for indicating GO in the short‐term, and improved resilience (RII = 0.879) and negative symptoms (RII = 0.858) as key items for indicating long‐term GO. Patients regarded building resilience (RII = 0.842) and having support from mental health services (RII = 0.833) as being protective for their mental health. These measures were included in a preliminary 12‐item GO checklist (GO‐12) for assessing GO in CHR‐P subjects.Conclusions: Patient‐defined measures of GO included items that are not incorporated into conventional measures of outcomes in CHR‐P subjects, such as subjective wellbeing and resilience. Integrating patient‐defined metrics of GO may improve the assessment of outcomes in the CHR‐P population.
- 26 May 2020
- Published by Wiley in Early Intervention in Psychiatry
- Vol. 15 (3) , 606-615
Open AccessExamining service‐user perspectives for the development of a good outcome checklist for individuals at clinical high risk for psychosis
Aims: Around 15% of patients at clinical high risk for psychosis (CHR‐P) experience symptomatic remission and functional recovery at follow‐up, yet the definition of a good outcome (GO) in this population requires further development. Outcomes are typically designed and rated by clinicians rather than patients, to measure adverse as opposed to GOs. Here we investigate how CHR‐P subjects define a GO, with the aim of developing a checklist that could be used to measure GO in this clinical group.Methods: A set of GO‐focused questions were designed in collaboration with a service‐user. CHR‐P patients (n = 48) were asked to rate the importance of items that could indicate short‐term (1 year) and long‐term (5 years) GO. These items were then ranked using the relative importance index (RII).Results: Patients rated improvement in subjective wellbeing (RII = 0.829) and non‐specific presenting symptoms (RII = 0.817) amongst the factors most important for indicating GO in the short‐term, and improved resilience (RII = 0.879) and negative symptoms (RII = 0.858) as key items for indicating long‐term GO. Patients regarded building resilience (RII = 0.842) and having support from mental health services (RII = 0.833) as being protective for their mental health. These measures were included in a preliminary 12‐item GO checklist (GO‐12) for assessing GO in CHR‐P subjects.Conclusions: Patient‐defined measures of GO included items that are not incorporated into conventional measures of outcomes in CHR‐P subjects, such as subjective wellbeing and resilience. Integrating patient‐defined metrics of GO may improve the assessment of outcomes in the CHR‐P population.
- Open Access
Normative modelling using deep autoencoders: a multi-cohort study on mild cognitive impairment and Alzheimer’s disease
Normative modelling is an emerging method for quantifying how individuals deviate from the healthy populational pattern. Several machine learning models have been implemented to develop normative models to investigate brain disorders, including regression, support vector machines and Gaussian process models. With the advance of deep learning technology, the use of deep neural networks has also been proposed. In this study, we assessed normative models based on deep autoencoders using structural neuroimaging data from patients with Alzheimer’s disease (n=206) and mild cognitive impairment (n=354). We first trained the autoencoder on an independent dataset (UK Biobank dataset) with 11,034 healthy controls. Then, we estimated how each patient deviated from this norm and established which brain regions were associated to this deviation. Finally, we compared the performance of our normative model against traditional classifiers. As expected, we found that patients exhibited deviations according to the severity of their clinical condition. The model identified medial temporal regions, including the hippocampus, and the ventricular system as critical regions for the calculation of the deviation score. Overall, the normative model had comparable cross-cohort generalizability to traditional classifiers. In order to promote open science, we are making all scripts and the trained models available to the wider research community.
Open AccessNormative modelling using deep autoencoders: a multi-cohort study on mild cognitive impairment and Alzheimer’s disease
Normative modelling is an emerging method for quantifying how individuals deviate from the healthy populational pattern. Several machine learning models have been implemented to develop normative models to investigate brain disorders, including regression, support vector machines and Gaussian process models. With the advance of deep learning technology, the use of deep neural networks has also been proposed. In this study, we assessed normative models based on deep autoencoders using structural neuroimaging data from patients with Alzheimer’s disease (n=206) and mild cognitive impairment (n=354). We first trained the autoencoder on an independent dataset (UK Biobank dataset) with 11,034 healthy controls. Then, we estimated how each patient deviated from this norm and established which brain regions were associated to this deviation. Finally, we compared the performance of our normative model against traditional classifiers. As expected, we found that patients exhibited deviations according to the severity of their clinical condition. The model identified medial temporal regions, including the hippocampus, and the ventricular system as critical regions for the calculation of the deviation score. Overall, the normative model had comparable cross-cohort generalizability to traditional classifiers. In order to promote open science, we are making all scripts and the trained models available to the wider research community.
- Open Access
- 20 December 2019
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 51 (2) , 340-350
Neuroanatomical abnormalities in first-episode psychosis across independent samples: a multi-centre mega-analysis
Background: Neuroanatomical abnormalities in first-episode psychosis (FEP) tend to be subtle and widespread. The vast majority of previous studies have used small samples, and therefore may have been underpowered. In addition, most studies have examined participants at a single research site, and therefore the results may be specific to the local sample investigated. Consequently, the findings reported in the existing literature are highly heterogeneous. This study aimed to overcome these issues by testing for neuroanatomical abnormalities in individuals with FEP that are expressed consistently across several independent samples.Methods: Structural Magnetic Resonance Imaging data were acquired from a total of 572 FEP and 502 age and gender comparable healthy controls at five sites. Voxel-based morphometry was used to investigate differences in grey matter volume (GMV) between the two groups. Statistical inferences were made at p < 0.05 after family-wise error correction for multiple comparisons.Results: FEP showed a widespread pattern of decreased GMV in fronto-temporal, insular and occipital regions bilaterally; these decreases were not dependent on anti-psychotic medication. The region with the most pronounced decrease – gyrus rectus – was negatively correlated with the severity of positive and negative symptoms.Conclusions: This study identified a consistent pattern of fronto-temporal, insular and occipital abnormalities in five independent FEP samples; furthermore, the extent of these alterations is dependent on the severity of symptoms and duration of illness. This provides evidence for reliable neuroanatomical alternations in FEP, expressed above and beyond site-related differences in anti-psychotic medication, scanning parameters and recruitment criteria.
- 20 December 2019
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 51 (2) , 340-350
Open AccessNeuroanatomical abnormalities in first-episode psychosis across independent samples: a multi-centre mega-analysis
Background: Neuroanatomical abnormalities in first-episode psychosis (FEP) tend to be subtle and widespread. The vast majority of previous studies have used small samples, and therefore may have been underpowered. In addition, most studies have examined participants at a single research site, and therefore the results may be specific to the local sample investigated. Consequently, the findings reported in the existing literature are highly heterogeneous. This study aimed to overcome these issues by testing for neuroanatomical abnormalities in individuals with FEP that are expressed consistently across several independent samples.Methods: Structural Magnetic Resonance Imaging data were acquired from a total of 572 FEP and 502 age and gender comparable healthy controls at five sites. Voxel-based morphometry was used to investigate differences in grey matter volume (GMV) between the two groups. Statistical inferences were made at p < 0.05 after family-wise error correction for multiple comparisons.Results: FEP showed a widespread pattern of decreased GMV in fronto-temporal, insular and occipital regions bilaterally; these decreases were not dependent on anti-psychotic medication. The region with the most pronounced decrease – gyrus rectus – was negatively correlated with the severity of positive and negative symptoms.Conclusions: This study identified a consistent pattern of fronto-temporal, insular and occipital abnormalities in five independent FEP samples; furthermore, the extent of these alterations is dependent on the severity of symptoms and duration of illness. This provides evidence for reliable neuroanatomical alternations in FEP, expressed above and beyond site-related differences in anti-psychotic medication, scanning parameters and recruitment criteria.